Nasym
bovine respiratory syncytial virus vaccine (live)
Table of contents
Overview
Nasym is a vaccine used to protect cattle against bovine respiratory syncytial virus, a disease that affects their airways. Nasym reduces shedding of virus and respiratory signs such as raised breathing rate, difficulty breathing, watery eyes and runny nose. Nasym contains bovine respiratory syncytial virus strain Lym-56.
Authorisation details
Product details | |
---|---|
Name |
Nasym
|
Agency product number |
EMEA/V/C/004897
|
Active substance |
live attenuated bovine respiratory syncytial virus (BRSV), strain Lym-56
|
International non-proprietary name (INN) or common name |
bovine respiratory syncytial virus vaccine (live)
|
Species |
Cattle
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI02AD04
|
Publication details | |
---|---|
Marketing-authorisation holder |
Laboratorios Hipra S.A.
|
Revision |
3
|
Date of issue of marketing authorisation valid throughout the European Union |
29/07/2019
|
Contact address |
Avda. La Selva, 135 |
Product information
26/02/2020 Nasym - EMEA/V/C/004897 - II/0003/G
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
-
Immunologicals for bovidae
-
Cattle
-
Live viral vaccines
-
bovine respiratory syncytial virus (BRSV)
Therapeutic indication
Active immunisation of cattle to reduce virus shedding and respiratory clinical signs caused by bovine respiratory syncytial virus infection.